AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
RACIAL-DIFFERENCES IN BONE-MINERAL DENSITY AMONG END-STAGE RENAL-DISEASE PATIENTS
Authors: STEHMANBREEN CO LINDBERG J SHERRARD DJ
Citation: Co. Stehmanbreen et al., RACIAL-DIFFERENCES IN BONE-MINERAL DENSITY AMONG END-STAGE RENAL-DISEASE PATIENTS, Journal of investigative medicine, 46(3), 1998, pp. 223-223
RELATIONSHIP OF IDIOPATHIC HYPOCITRATURIA AND LOW GASTROINTESTINAL (GI) ABSORPTION OF ALKALI
Authors: BEDEIR S LINDBERG J COLE F NEUSETZER S THEZAN G HAMM L
Citation: S. Bedeir et al., RELATIONSHIP OF IDIOPATHIC HYPOCITRATURIA AND LOW GASTROINTESTINAL (GI) ABSORPTION OF ALKALI, Journal of investigative medicine, 46(1), 1998, pp. 20-20
19-NOR-1-ALPHA-25-DIHYDROXYVITAMIN D-2 (PARICALCITOL) SAFELY AND EFFECTIVELY REDUCES THE LEVELS OF INTACT PARATHYROID-HORMONE IN PATIENTS ON HEMODIALYSIS
Authors: MARTIN KJ GONZALEZ EA GELLENS M HAMM LL ABBOUD H LINDBERG J
Citation: Kj. Martin et al., 19-NOR-1-ALPHA-25-DIHYDROXYVITAMIN D-2 (PARICALCITOL) SAFELY AND EFFECTIVELY REDUCES THE LEVELS OF INTACT PARATHYROID-HORMONE IN PATIENTS ON HEMODIALYSIS, Journal of the American Society of Nephrology, 9(8), 1998, pp. 1427-1432
A 3-DIMENSIONAL MODEL OF THE FAS APO-1 MOLECULE - CROSS-REACTIVITY OFANTI-FAS ANTIBODIES EXPLAINED BY STRUCTURAL MIMICRY OF ANTIGENIC SITES/
Authors: FADEEL B LINDBERG J ACHOUR A CHIODI F
Citation: B. Fadeel et al., A 3-DIMENSIONAL MODEL OF THE FAS APO-1 MOLECULE - CROSS-REACTIVITY OFANTI-FAS ANTIBODIES EXPLAINED BY STRUCTURAL MIMICRY OF ANTIGENIC SITES/, International immunology, 10(2), 1998, pp. 131-140
ANTIBODY-LEVELS IN ETHIOPIAN CHILDREN 5 YEARS AFTER VACCINATION WITH 2 DIFFERENT DOSES OF HEPATITIS-B VACCINE - IS THERE A NEED FOR BOOSTERVACCINE
Authors: TSEGA E HORTON J NORDENFELT E HANSSON BJ TAFESSE B WOLDEHAWARIAT G LINDBERG J
Citation: E. Tsega et al., ANTIBODY-LEVELS IN ETHIOPIAN CHILDREN 5 YEARS AFTER VACCINATION WITH 2 DIFFERENT DOSES OF HEPATITIS-B VACCINE - IS THERE A NEED FOR BOOSTERVACCINE, Canadian journal of gastroenterology, 12(1), 1998, pp. 57-60
THERAPY OF SECONDARY HYPERPARATHYROIDISM WITH 19-NOR-1-ALPHA,25-DIHYDROXYVITAMIN D-2
Authors: MARTIN KJ GONZALEZ EA GELLENS ME HAMM LL ABBOUD H LINDBERG J
Citation: Kj. Martin et al., THERAPY OF SECONDARY HYPERPARATHYROIDISM WITH 19-NOR-1-ALPHA,25-DIHYDROXYVITAMIN D-2, American journal of kidney diseases, 32(2), 1998, pp. 61-66
THE ISCHEMIC OPTIC NEUROPATHY DECOMPRESSION TRIAL (IONDT) - DESIGN AND METHODS
Authors: KENNERDELL J TYUTYUNIKOV A EDWARDS R GOODGLICK T LANG D PEELE K CHUNG S KNAUP P MEKELBURG D HOLDS J SELHORST J MALTON M ARMSTRONG S MCCRACKEN Y BENJAMIN E BROOKS E DELLINGER C MEDLIN TH KINSLER B MCOWEN M RUSSELL D SAUNDERS T KOSMORSKY G KISS T REINHARD C EDGERTON J FECKO T HANSON S KRAUS B ROSS D TOMSAK N VARGO P WALSH L WILLIS R FELDON S LEVIN L ZIMMERMAN K ANDERSON K CORTEZ R DEBLANC K HULSE J MORALES R NICHOLS T REYES L RODARTEOCHOA N ROMO D SADUN A STEBER M WALONKER F NEWMAN NJ LOUPE D COFFMAN D COLE H WOJNO T SKARF B WOJTALA C CROSWELL M GILROY W MAGELI C MCDONALD D PONKA G TANG R HAMLIN M CURTIS J HYDE K MACK K TELLO P ARNOLD A MULLEN M CIBENER B VEGA M BALLENBERG B BOLTON A GARCIA J GOLDBERG R GORDON L HENEGHAN M KRAUS H SANGUINET J STALLING R YADEGARAN J CORNBLATH W MICHAEL B CAMPBELL D CAUDILL C NELSON C TROBE J JOHNSON LN BAKER G COBB C CUSTER P TURNER S WILSON R YOUNGE B LEAVITT J NIELSEN R ALLEN J EICKHOFF B GARRITY J LADSTEN J LEBARRON K LINK T ROSTVOLD J WEBER K FELTON W OLIVER T SMITH S GABRIEL D DAVID D FENDELANDER L GELLER D JORDAN T KIM C MUNGER C ROMANDY JA SANBORN G SCHWARTZ B SHEUSI C SMITH C TALLEY K THIMMAPPA S KAUFMAN D EGGENBERGER E BICKERT S GRANADIER R HOLLIDAY S MOORE T VARADARAJAN J FRIEDMAN D JONES P AMIN H BERSANI T BRIGLIN C FOOKS J GRAHAM M JAMES M MICHALEC G NGUYEN H HORTON J CHANG M ABER LA LINDSTROM E SEIFF S GUY J ZAM ZS FRANCIS A HAMED L LESSNER A MCDAVID D SHAMIS D GOODWIN J LINDEMAN ME SULLIVAN E BOBAK P PUTTERMAN A BAKER R BECK J COWEN D EPSTEIN A HANSON M SCOGGINS T KELMAN S FRANK C BLAKE A RODAVITCH AM GORE B HEROUX M KALSI R KRAUCH C MILLAR MA CHALAM K WOLIN M MUNN B BRADY RJ HANSEN R BRIGGS M DANNER B SIMONS B STEWART A DIGRE K ERICKSON J MALMQUISTWEBB L BLACKBURN T BAGGALEY S ANDERSON R JUAREZ C KAYE B LANGER P MISHRA A MORRIS P OSBORN S PATEL B STAKER S WARNER J NEWMAN S EVANS C AYLOR A CHILDRESS C DICKERSON H FLEMING J HARRIS N HOYLE LS MURPHY E SCOTT J SMALL T SUMMERVILLE K TERRELL M TYLER L LINDBERG J ELLIS B BREEN L MICHAEL M CAMPBELL C GROVES N HOBSON R MCGREGOR G SHEPHERD L COHN E CUMMING K MANATREY P CASEY S JOHNSON J KRONNER C REGAN V STREASICK P ELMAN M METZEL D DICKERSIN K HOOPER F SCHERER R CRAWLEY B HINER C HOWARD L LAGENBERG P LURYE O MASIERO J MCCARTER R RIEDEL S SOTOS M SPIOCH L STARR J URBAN J WARING M WILSON PD EVERETT D FISHER M AITKEN P BECK R LACROIX A LESSELL S MACLEAN K KOSMORSKY D SEIFF SR
Citation: J. Kennerdell et al., THE ISCHEMIC OPTIC NEUROPATHY DECOMPRESSION TRIAL (IONDT) - DESIGN AND METHODS, Controlled clinical trials, 19(3), 1998, pp. 276-296
AGGLOMERATION INHIBITION REFLECTED STONE-FORMING ACTIVITY DURING LONG-TERM POTASSIUM CITRATE THERAPY IN CALCIUM STONE FORMERS
Authors: FUSELIER HA MOORE K LINDBERG J HUSSERL FE COLE FE KOK DJ WHITEHEAD D GALLIANO DJ ERWIN DT
Citation: Ha. Fuselier et al., AGGLOMERATION INHIBITION REFLECTED STONE-FORMING ACTIVITY DURING LONG-TERM POTASSIUM CITRATE THERAPY IN CALCIUM STONE FORMERS, Urology, 52(6), 1998, pp. 988-994
CYCLOSPORINE TO TACROLIMUS - EFFECT ON HYPERTENSION AND LIPID PROFILES IN RENAL-ALLOGRAFTS
Authors: COPLEY JB STAFFELD C LINDBERG J HANSEN A BAILEY C ANAND R VANVELDHUISEN P
Citation: Jb. Copley et al., CYCLOSPORINE TO TACROLIMUS - EFFECT ON HYPERTENSION AND LIPID PROFILES IN RENAL-ALLOGRAFTS, Transplantation proceedings, 30(4), 1998, pp. 1254-1256
SPODIC MATERIAL FOR IN-SITU TREATMENT OF ARSENIC IN-GROUND WATER
Authors: LINDBERG J STERNELAND J JOHANSSON PO GUSTAFSSON JP
Citation: J. Lindberg et al., SPODIC MATERIAL FOR IN-SITU TREATMENT OF ARSENIC IN-GROUND WATER, Ground water monitoring & remediation, 17(4), 1997, pp. 125-130
LOW GASTROINTESTINAL ABSORPTION OF ALKALI AS A CAUSE OF IDIOPATHIC HYPOCITRATURIA
Authors: BEDEIR S LINDBERG J COLE F NEUSETZER S THEZAN G HAMM L
Citation: S. Bedeir et al., LOW GASTROINTESTINAL ABSORPTION OF ALKALI AS A CAUSE OF IDIOPATHIC HYPOCITRATURIA, Journal of the American Society of Nephrology, 8, 1997, pp. 484-484
AGGLOMERATION INHIBITION [TM] REFLECTED STONE ACTIVITY DURING 4 YEARSOF POTASSIUM CITRATE THERAPY (K-CIT-RX) IN CALCIUM STONE FORMERS (CASF)
Authors: LINDBERG J FUSELIER HA MOORE K HUSSERL F COLE FE WHITEHEAD D GALLIANO D KOK DJ ERWIN DT
Citation: J. Lindberg et al., AGGLOMERATION INHIBITION [TM] REFLECTED STONE ACTIVITY DURING 4 YEARSOF POTASSIUM CITRATE THERAPY (K-CIT-RX) IN CALCIUM STONE FORMERS (CASF), Journal of the American Society of Nephrology, 8, 1997, pp. 2630-2630
NEUROCHEMICAL CHANGES IN THE HIPPOCAMPUS OF THE BROWN-NORWAY RAT DURING AGING
Authors: BHATNAGAR M CINTRA A CHADI G LINDBERG J OITZL M DEKLOET ER MOLLER A AGNATI LF FUXE K
Citation: M. Bhatnagar et al., NEUROCHEMICAL CHANGES IN THE HIPPOCAMPUS OF THE BROWN-NORWAY RAT DURING AGING, Neurobiology of aging, 18(3), 1997, pp. 319-327
LIVER REACTIONS TO ORAL LOW-DOSE TETRACYCLINES
Authors: BJORNSSON E LINDBERG J OLSSON R
Citation: E. Bjornsson et al., LIVER REACTIONS TO ORAL LOW-DOSE TETRACYCLINES, Scandinavian journal of gastroenterology, 32(4), 1997, pp. 390-395
THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS
Authors: CAMPEAU L KNATTERUD GLMK DOMANSKI M HUNNINGHAKE DB WHITE CW GELLER NL ROSENBERG Y HERD A COCANOUGHER MK DUNN K FARMER J FOREYT J GREGORY K INSULL W JACKSON M KLEIMAN N LEWIS R LLOYD C MARESH K MATTHEW C MINOR S ROBERTS R SALMON A SHACKELFORD P STEWART R THOMPSON M YOUNG J GUINN A HARRIS G HEIBIG J LEVY VV FORRESTER J HICKEY A BUCHBINDER N DAVIDSON R DRURY K EBER L EIGLER N GEFT I GOLDBERG S GRODAN P HENDEL J HIGGINS S HODGSON T HUGHES L KARLSBERG R KATZ J LEPOR N LITVAK F LUPTAK Y MADERA G MARCUS H MONDKAR A NEIDORF B NEUMANN M NIVATPUMIN T RABINOWITZ Y RAYMOND M READER A RURYCZ V SCHAPIRA J SCHLANGER J SILVERBERG R SMITH A TABAK S VALOVIS R GRAY R HOOGWERF B STEWART W BAERVEDT G BOTTSILVERMAN C BREEN C BUCKNER P CABRAL J CRESSMAN M FONSECA C FOSTER J FOSTER R GUTMAN F HARRIS L HEUPLER F HOBBS R HUANG S KALENAK J KASSEM M KOSMORSKY G KRAMER J KURZAWA C LANGSTON R LINCOFF M LINDBERG J LOWDER C MCCAFFERTY F MCKEOWN D MEISLER D MENDLOVIC D MEYERS S MOORE J NOUSEK J RAYMOND R RINCON G ROBIN J ROCKWOOD E SHELDON W SIMPFENDORFER C WALSH H WANESS A WRIGHT K YANAK F GOULET C BEDARD H BOIS M BUJOLD S COTE G DAVIGNON J DEBELDER M DUCHARME AM DOUCET S DUMAS J DYDRA I FOUCHER S CREPEAU J GOSSELIN G GROULX D JOYAL M JUNEAU M LESPERANCE J LEVESQUE C LEVESQUE J MARCIL M OLIVIER M PASTERNAC A POITRAS AM POITRAS D QUEVILLON A RIOUX C ROBITAILLE D SISOUPHONE K SOLYMOSS C HUNNINGHAKE D CHRISTIANSON B DIANGELIS N GARDNER K HELGREN R IACARELLA C KNOBLOCH W LAU L LAXSON D LEON A LONDON E MANION R MCDONALD K MCGINN A MIANULLI M ROBINSON J TURNER G WANG Y WHITE C WILSON R ZIMMER S GOBEL F ANDERSON P BAUMGARD C CHRISTENSEN J FULCO A HANSON K JOHNSON C LARSON B MADISON J MCCORMACK P OSTROV C PECHA R PEDERSON W PIER T RANDALL M RODMAN W ROELLER S SCOTT K SHER N SPEILMAN J THOMPSON R ZUPFER S GOLDENBERG I HEALY B KNATTERUD G TERRIN M CANNER M FICK S FORMAN S HANSON D HOWARD J HUANG AL KARABELAS S LOPRESTI F MERCER W RA K RANDALL A SCHACTMAN M SCHLEIGH B SNIDER R MIRENZI E FISHER M FOX NL CZAJKOWSKI S GELLER N PROBSTFIELD J SHUMAKER S WITTES J YUSUF S ZUCKER D CARTLAND J DAS G MEYER S POWERS T RINGDAL D ROSZA Z SHAHEEN B SIREK M STONE C SNIDER J VANYI J ALAUPOVIC P FESMIRE J WALENGA J BERMES E HOPPENSTEADT D PIFARRE R CARLETON R BAILEY K BRODY B CAIRNS J FURBERG C FUSTER V GRONDIN C JENKINS D LAROSA J MEIER P
Citation: L. Campeau et al., THE EFFECT OF AGGRESSIVE LOWERING OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS AND LOW-DOSE ANTICOAGULATION ON OBSTRUCTIVE CHANGES IN SAPHENOUS-VEIN CORONARY-ARTERY BYPASS GRAFTS, The New England journal of medicine, 336(3), 1997, pp. 153-162
19-NOR-1-ALPHA,25-DIHYDROXYVITAMIN D-2 (19-NOR) - AN EFFECTIVE VITAMIN-D ANALOG SUPPRESSES PTH SECRETION IN HEMODIALYSIS (HD) PATIENTS
Authors: LLACH F GOLDBLATT MV LINDBERG J NAQUIN J DELMEZ J ARRUDA J LAU A BUSCHEN C AMDAHL M SLATOPOLSKY E
Citation: F. Llach et al., 19-NOR-1-ALPHA,25-DIHYDROXYVITAMIN D-2 (19-NOR) - AN EFFECTIVE VITAMIN-D ANALOG SUPPRESSES PTH SECRETION IN HEMODIALYSIS (HD) PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2732-2732
URINARY INHIBITORS BEFORE AND DURING POTASSIUM CITRATE THERAPY
Authors: ERWIN DT LINDBERG J HUSSERL F FUSELIER H KOK D COLE FE
Citation: Dt. Erwin et al., URINARY INHIBITORS BEFORE AND DURING POTASSIUM CITRATE THERAPY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2768-2768
LACK OF EFFECTS OF ERYTHROPOIETIN (EPO) ON PROLACTIN (PRL) LEVELS ANDHYPOGONADISM (HG) IN PATIENTS (PTS) WITH CHRONIC-RENAL-FAILURE (CRF)
Authors: LINDBERG J SMITH S HUSSERL FE ROSS J MARQUEZJULIO A FIGUEROA J ERWIN DT NAQUIN J COPLEY J
Citation: J. Lindberg et al., LACK OF EFFECTS OF ERYTHROPOIETIN (EPO) ON PROLACTIN (PRL) LEVELS ANDHYPOGONADISM (HG) IN PATIENTS (PTS) WITH CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 7(9), 1996, pp. 2847-2847
DOPAMINE D-1 RECEPTOR-MEDIATED FACILITATION OF GABAERGIC NEUROTRANSMISSION IN THE RAT STRIOENTOPEDUNCULAR PATHWAY AND ITS MODULATION BY ADENOSINE A(1) RECEPTOR-MEDIATED MECHANISMS
Authors: FERRE S OCONNOR WT SVENNINGSSON P BJORKLUND L LINDBERG J TINNER B STROMBERG I GOLDSTEIN M OGREN SO UNGERSTEDT U FREDHOLM BB FUXE K
Citation: S. Ferre et al., DOPAMINE D-1 RECEPTOR-MEDIATED FACILITATION OF GABAERGIC NEUROTRANSMISSION IN THE RAT STRIOENTOPEDUNCULAR PATHWAY AND ITS MODULATION BY ADENOSINE A(1) RECEPTOR-MEDIATED MECHANISMS, European journal of neuroscience, 8(7), 1996, pp. 1545-1553
PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B
Authors: KROGSGAARD K MARCELLIN P TREPO C BERTHELOT P SANCHEZTAPIAS JM BASSENDINE M TRAN A OUZAN D RINGLARSEN H LINDBERG J ENRIQUEZ J BENHAMOU JP BINDSLEV N BERTET S BOYER N BRIND A CIVEIRA MP HOUSSET C LUNDLAURSEN A MAS A POL S PRIETO J QUEDENS J RAMPAL P SCHLICHTING P SORIANO G SPACEY BEM HAWLEY S BRAND C HOWE I
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 803-813
URINE FROM CALCIUM-OXALATE (CAOX) STONE FORMERS (SD) WITH ADDED PHOSPHOCITRATE ENHANCED INHIBITION OF CAOX MONOHYDRATE (COM), AGGLOMERATIONKINETICS, [TM], AND CRYSTAL-GROWTH, PERCENT-GI
Authors: ERWIN DT SALLIS JD LINDBERG J HUSSERL F ALAM J KOK D ALLEN J FUSELIER H COLE FE
Citation: Dt. Erwin et al., URINE FROM CALCIUM-OXALATE (CAOX) STONE FORMERS (SD) WITH ADDED PHOSPHOCITRATE ENHANCED INHIBITION OF CAOX MONOHYDRATE (COM), AGGLOMERATIONKINETICS, [TM], AND CRYSTAL-GROWTH, PERCENT-GI, Journal of the American Society of Nephrology, 6(3), 1995, pp. 462-462
LONG-DISTANCE PATHWAYS OF DIFFUSION FOR DEXTRAN ALONG FIBER-BUNDLES IN BRAIN - RELEVANCE DOR VOLUME TRANSMISSION
Authors: BJELKE B ENGLAND R NICHOLSON C RICE ME LINDBERG J ZOLI M AGNATI LF FUXE K
Citation: B. Bjelke et al., LONG-DISTANCE PATHWAYS OF DIFFUSION FOR DEXTRAN ALONG FIBER-BUNDLES IN BRAIN - RELEVANCE DOR VOLUME TRANSMISSION, NeuroReport, 6(7), 1995, pp. 1005-1009
EPIDEMIOLOGIC ASPECTS OF INFECTIVE ENDOCARDITIS IN AN URBAN-POPULATION - A 5-YEAR PROSPECTIVE-STUDY
Authors: HOGEVIK H OLAISON L ANDERSSON R LINDBERG J ALESTIG K
Citation: H. Hogevik et al., EPIDEMIOLOGIC ASPECTS OF INFECTIVE ENDOCARDITIS IN AN URBAN-POPULATION - A 5-YEAR PROSPECTIVE-STUDY, Medicine, 74(6), 1995, pp. 324-339
RANDOMIZED TRIAL COMPARING RHEOLYTIC THROMBECTOMY TO SURGICAL EMBOLECTOMY FOR THROMBOSED HEMODIALYSIS GRAFTS AND PERIPHERAL ARTERIES - AN INTERIM-REPORT
Authors: RAMEE SR LANSKY AJ MONEY SR LINDBERG J GRIFFIN S JENKINS JS SHAW D
Citation: Sr. Ramee et al., RANDOMIZED TRIAL COMPARING RHEOLYTIC THROMBECTOMY TO SURGICAL EMBOLECTOMY FOR THROMBOSED HEMODIALYSIS GRAFTS AND PERIPHERAL ARTERIES - AN INTERIM-REPORT, Circulation, 92(8), 1995, pp. 267-267
ASSESSMENT OF POSTOPERATIVE RENAL-FUNCTION (RF) FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION (OLT) IN PATIENTS (PTS) WITH ELEVATED BLOOD UREANITROGEN (BUN) TO CREATININE (CR) RATIOS
Authors: COPLEY J LINDBERG J CROCKETT S HARPER J WADE C
Citation: J. Copley et al., ASSESSMENT OF POSTOPERATIVE RENAL-FUNCTION (RF) FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION (OLT) IN PATIENTS (PTS) WITH ELEVATED BLOOD UREANITROGEN (BUN) TO CREATININE (CR) RATIOS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 390-390
Risultati: 1-25 | 26-39